{
    "2019-07-26": [
        [
            {
                "time": "2019-07-26",
                "original_text": "AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises EPS View",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Q2 Earnings",
                        "Beats",
                        "Raises EPS"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-26",
                "original_text": "Senate advances bill to cut the cost of prescriptions",
                "features": {
                    "keywords": [
                        "Senate",
                        "bill",
                        "cut cost",
                        "prescriptions"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-26",
                "original_text": "Health Care Sector Update for 07/26/2019: EHTH, CUR, VSTM, SNY, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "EHTH",
                        "CUR",
                        "VSTM",
                        "SNY",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-26",
                "original_text": "Is the Colombian Cannabis Industry Leading Latin America, Or Just Leading Investors On A Wild Goose Chase?",
                "features": {
                    "keywords": [
                        "Colombian",
                        "Cannabis",
                        "Industry",
                        "Latin America",
                        "Investors",
                        "Wild Goose Chase"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-26",
                "original_text": "The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Obseva",
                        "Greenlight",
                        "Verastem",
                        "Licensing Deal",
                        "Merit Medical",
                        "Earnings Disappoint"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2019-07-26",
                "original_text": "Drugmakers: Our Take on Earnings",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "Earnings"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}